Future Social Worker Sharde Fultz Pays It Forward
We first met the incredible Sharde Fultz in our very first season of Marrow Masters, back in 2019. We wanted to reconnect with her as one our our "survivors who thrive" this season.
In 2009, Sharde was a college student, living on campus as a dance major with big dreams. Then she was diagnosed with non-Hodgkins Lymphoma. Following chemotherapy and radiation, Sharde received an an allogeneic bone marrow transplant in 2011. Having to leave school, she immersed herself in online support forums for young adult cancer patients.
When Sharde returned to school, between her recovery and chronic GVHD, she had to come to terms with some physical limitations. While she still had a passion for dance, she'd need to pivot. Her time interacting with fellow cancer survivors really sparked something in her. She wanted to be able to related to not just other patients, but also people who looked like her. She could fight against some of the inequities in our health care system.
Sharde connected with an organization called Next Step, which sends people on "campferences" - part camp, part conference. She attended a campference in 2010, and now works for the organization. Speaking engagements turned into a facilitator role for young adult cancer camps. She's now the conference director, and is working toward a degree in social work.
Sharde's advice for fellow cancer survivors is to change how you think about time, and don't compare your journey to anyone else's progress.
Next Step Fund website: https://www.nextstepnet.org/
Cassie Hines Shoes Cancer: https://cassiehinesshoescancer.org/
Stupid Cancer: https://stupidcancer.org/
First Descents: https://firstdescents.org/
Camp Mak-A-Dream: https://www.campdream.org/
Other Resources
National Bone Marrow Transplant Link - (800) LINK-BMT, or (800) 546-5268.
nbmtLINK Website: https://www.nbmtlink.org/
nbmtLINK Facebook Page: https://www.facebook.com/nbmtLINK
nbmtLINK YouTube Page can be found by clicking here.
Thank you to our sponsors. This season is supported by a healthcare contribution from Sanofi and The Leukemia & Lymphoma Society.